INMD
InMode Ltd
NASDAQ: INMD · HEALTHCARE · MEDICAL DEVICES
$14.05
-0.07% today
Updated 2026-06-03
Market cap
$823.35M
P/E ratio
10.03
P/S ratio
2.20x
EPS (TTM)
$1.35
Dividend yield
—
52W range
$13 – $17
Volume
0.9M
WallStSmart proprietary scores
54
out of 100
Grade: C
Hold
Investment rating
3.3
Growth
D8.5
Quality
A6.5
Profitability
B7.3
Valuation
B+2/9
Piotroski F-Score
Weak
8.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$14.33
+1.99%
12-Month target
$11.01
-21.64%
Intrinsic (DCF)
$34.72
Margin of safety
+58.99%
0 Strong Buy0 Buy5 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 8.64 — safe zone
+ Profit margin 23.30% — above average
+ Free cash flow $15.21M — positive
+ 58.99% below intrinsic value
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $454.27M | $492.05M | $394.82M | $370.50M | $374.64M |
| Net income | $161.52M | $197.92M | $181.28M | $93.83M | $11.56M |
| EPS | — | — | — | — | $1.35 |
| Free cash flow | $180.00M | $176.12M | $132.00M | $84.28M | $15.21M |
| Profit margin | 35.56% | 40.22% | 45.91% | 25.33% | 23.30% |
Peer comparison
Smart narrative
InMode Ltd trades at $14.05. representing a P/E of 10.03x trailing earnings. Our Smart Value Score of 54/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 8.64, it sits in the safe zone. TTM revenue stands at $374.64M. with profit margins at 23.30%. Our DCF model estimates intrinsic value at $34.72.
Frequently asked questions
What is InMode Ltd's stock price?
InMode Ltd (INMD) trades at $14.05, on a P/E of 10.0x and a P/S of 2.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is InMode Ltd overvalued?
InMode Ltd carries a Smart Value Score of 54/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $34.72 versus the $14.05 price, a 59.0% margin of safety on a cash flow basis.
What is the price target of InMode Ltd (INMD)?
The 12-month analyst consensus target is $14.33, about 2.0% above the current $14.05. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of INMD by 2030?
Our research-backed model puts the 2030 base case at $22.75, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of InMode Ltd (INMD)?
Our DCF model estimates intrinsic value at $34.72, a +59.0% margin of safety versus today's $14.05. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is InMode Ltd's revenue?
InMode Ltd's trailing twelve-month revenue is $374.64M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
InMode Ltd's Altman Z-Score is 8.64, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.20x
ROE13.19%
Beta1.93
50D MA$13.96
200D MA$14.44
Shares out0.06B
Float0.05B
Short ratio—
Avg volume0.9M
Performance
1 week+0.00%
1 month-3.99%
3 months-0.37%
YTD-8.17%
1 year—
3 years—
5 years—